Literature DB >> 17300634

Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control.

William R Brieger1, Joseph C Okeibunor, Adenike O Abiose, Richard Ndyomugyenyi, William Kisoka, Samuel Wanji, Elizabeth Elhassan, Uche V Amazigo.   

Abstract

The African Programme for Onchocerciasis Control (APOC) sponsors annual distribution of ivermectin to control onchocerciasis. Ivermectin should be taken annually by 65% of community members for a number of years to eliminate the disease as a public health problem. While many community coverage surveys have been undertaken during project monitoring, individual compliance could not be studied until several annual rounds of distribution had occurred. This paper reports on the efforts to determine whether adequate records could be found to enable a compliance study. A step-down process from project to district to community level was used to identify project sites where continuous ivermectin distribution up through 2004 had occurred. The first step consisted of selecting 17 of 25 projects by APOC. The second step determined adequacy of districts where distribution had occurred on a regular annual basis. Among 121 districts 58.6% undertook distribution in all 7 years. A total 852 villages were visited and community level records were found in all but three. Records showed that distribution had occurred for a minimum of five consecutive times in 429 villages, and ultimately 10 projects. While the feasibility study found an adequate number of villages to study compliance, the large number of projects, districts and villages that did not qualify for the follow-on compliance study should lead National Onchocerciasis Control Programme managers to strengthen the overall coverage and consistency of their efforts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300634     DOI: 10.1111/j.1365-3156.2006.01796.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  9 in total

1.  Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin.

Authors:  Moses N Katabarwa; Tom Lakwo; Peace Habomugisha; Stella Agunyo; Edson Byamukama; David Oguttu; Ephraim Tukesiga; Dickson Unoba; Patrick Dramuke; Ambrose Onapa; Edridah M Tukahebwa; Dennis Lwamafa; Frank Walsh; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2013-05-20       Impact factor: 2.345

2.  Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.

Authors:  Samuel Wanji; Nicholas Tendongfor; Theolbald Nji; Mathias Esum; Julious N Che; Armand Nkwescheu; Fifen Alassa; Geremy Kamnang; Peter A Enyong; Mark J Taylor; Achim Hoerauf; David W Taylor
Journal:  Parasit Vectors       Date:  2009-08-27       Impact factor: 3.876

3.  Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.

Authors:  Guy-Roger Kamga; Fanny N Dissak-Delon; Hugues C Nana-Djeunga; Benjamin D Biholong; Stephen Mbigha Ghogomu; Jacob Souopgui; Joseph Kamgno; Annie Robert
Journal:  Parasit Vectors       Date:  2018-06-19       Impact factor: 4.047

4.  Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.

Authors:  Guy-Roger Kamga; Fanny N Dissak-Delon; Hugues C Nana-Djeunga; Benjamin D Biholong; Stephen Mbigha-Ghogomu; Jacob Souopgui; Honorat G M Zoure; Michel Boussinesq; Joseph Kamgno; Annie Robert
Journal:  Parasit Vectors       Date:  2016-11-14       Impact factor: 3.876

5.  Important progress towards elimination of onchocerciasis in the West Region of Cameroon.

Authors:  Guy-Roger Kamga; Fanny N Dissak-Delon; Hugues C Nana-Djeunga; Benjamin D Biholong; Stephen Mbigha Ghogomu; Jacob Souopgui; Joseph Kamgno; Annie Robert
Journal:  Parasit Vectors       Date:  2017-08-03       Impact factor: 3.876

Review 6.  Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.

Authors:  Gebremedhin Gebrezgabiher; Zeleke Mekonnen; Delenasaw Yewhalaw; Asrat Hailu
Journal:  Infect Dis Poverty       Date:  2019-07-04       Impact factor: 10.485

7.  Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia.

Authors:  Gebremedhin Gebrezgabiher; Delenasaw Yewhalaw; Asrat Hailu; Zeleke Mekonnen
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

8.  Low levels of awareness despite high prevalence of schistosomiasis among communities in Nyalenda informal settlement, Kisumu city, western Kenya.

Authors:  Gladys O Odhiambo; Rosemary M Musuva; Vincent O Atuncha; Elizabeth T Mutete; Maurice R Odiere; Rosebella O Onyango; Jane A Alaii; Pauline N M Mwinzi
Journal:  PLoS Negl Trop Dis       Date:  2014-04-03

Review 9.  Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.

Authors:  Kathryn V Shuford; Hugo C Turner; Roy M Anderson
Journal:  Parasit Vectors       Date:  2016-01-27       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.